Atlas Trials

ExeNTrO: Exercise During Neoadjuvant Chemoradiation Treatment to Improve Rectal and Esophageal Cancer Outcome - Pilot Trial

Clinical trial NCT05686213 · UNKNOWN

Trial details

NCT number
NCT05686213
Sponsor
Radboud University Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Oncology
Start date
2022-09-01
Primary completion
2024-03-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.